title: Subacute cutaneous lupus erythematosus after treatment with capecitabine.
authors.forename: Sabrina
authors.initials: S
authors.lastname: Kindem
authors.forename: Beatriz
authors.initials: B
authors.lastname: Llombart
authors.forename: Celia
authors.initials: C
authors.lastname: Requena
authors.forename: Amparo
authors.initials: A
authors.lastname: Ruiz
authors.forename: Victor
authors.initials: V
authors.lastname: Traves
authors.forename: Carlos
authors.initials: C
authors.lastname: Guillen
authors.forename: Onofre
authors.initials: O
authors.lastname: San Martin
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil